Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
alcohol
amphetamines
analgesic
anesthesia, general
anesthesia, local
antibiotics
antibiotics, neurologic complications with
anticholinesterase
anticonvulsants
anticonvulsants, bioavailability
anticonvulsants, dosage
anticonvulsants, loading dose
anticonvulsants, metabolism
anticonvulsants, parenteral administration
anticonvulsants, pharmacokinetics
anticonvulsants, selection of
anticonvulsants, untoward effects of
antidepressant
baclofen
beta adrenergic blocker
camphor
children
chlorambucil
cocaine
contrast agents, neurotoxicity of
cost effectiveness
cyclosporine
dilantin
dilantin, intravenous
dilantin, toxicity
drug abuse
drug induced neurologic disorders
drug interactions
efficacy
ephedrine
ergonovine
folic acid
fosphenytoin
hyperbaric oxygen
hyperbaric treatment
iatrogenic neurologic disorders
intravenous
lidocaine
marihuana
nalidixic acid
narcotic analgesics
old age, neurology of
penicillin
phencyclidine poisoning
phenobarbital
phenylpropanolamine
physostigmine
propofol
propranolol
purple glove syndrome
purple hands
review article
risk factors
seizure
seizure, children
seizure, drug-induced
seizure, elderly
seizure, treatment of
sodium valproate
sodium valproate, intravenous
status epilepticus
sympathomimetic drugs
treatment of neurologic disorder
valium
vitamin K
Showing articles 1000 to 1050 of 1724 << Previous Next >>

Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998

Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998

Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998

Parenteral Fosphenytoin:Efficacy and Economic Considerations
The Neurologist 4:S30-S34, Ramsay,R.E.&Wilder,B.J., 1998

Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users
Arch Int Med 158:2043-2050, Ribera,E.,et al, 1998

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

Memory Impairment in Abstinent MDMA ("Ecstast") Users
Neurol 51:1532-1537, Bolla,K.I.,et al, 1998

Mild Traumatic Brain Injury,Toward Understanding Manifestations and Treatment
Arch Int Med 158:90-97, Kushner,D., 1998

Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998

Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998

Progressive Multifocal Leukoencephalopathy in Patients with HIV Infection
J Neurovirol 4:59-68, Berger,J.R., 1998

Chronic Neutrophilic Meningitis Caused by Candida Albicans
Neurologia 13:362-366, del Pozo, M.M.,et al, 1998

Candidal Meningitis in HIV-Infected Patients: Analysis of 14 Cases
Clin Inf Dis 25:473-476, Casado, J.L.,et al, 1997

Generalized Efficacy of t-PA for Acute Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2119-21251997., , 1997

Should Thrombolytic Therapy be the First-Line Treatment for Acute Ischemic Stroke
NEJM 337:1309-1313, Caplan,L.R.,et al, 1997

Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997

Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997

Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997

Clinical Trial of Plasma Exchange and High-dose Intravenous Immunoglobulin in Myasthenia Gravis
Ann Neurol 41:789-796, Gajdos,P.,et al, 1997

Intensive Care of the Myasthenic Patient
Neurol 48 (Suppl 5) :S70-S75997., Mayer,S.A., 1997

Aluminum Neurotoxicity in Preterm Infants Receiving Intravenous-Feeding Solutions
NEJM 336:1557-1561, Bishop,N.J.,et al, 1997

Color Vision Test for Early Detection of Antiepileptic Drug Toxicity
Neurol 48:1394-1397, Bayer,A.U.,et al, 1997

The Use of Self Infused IVIG Home Therapy in Trtm of Acquired Chronic Demyel Neuropathies
JNNP 63:106-109, Sewell,W.A.C.,et al, 1997

Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997

Cerebral Tuberculosis in Pts with AIDS, Report of 6 Cases & Review
Medicine 76:423-431, Lesprit,P.,et al, 1997

The Therapeutic Dilemma of Inclusion Body Myositis
Neurol 48:567-568, Barohn,R.J., 1997

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Correlation of Clinical, Magnetic Resonance Imaging, and Cerebrospinal Fluid Findings in Optic Neuritis
Ann Neurol 41:392-398, Jacobs,L.D.,et al, 1997

CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997

Gluteal Compartment Syndrome Due to Rhabdomyolysis After Heroin Abuse
Neurol 48:275-276, Klockgether,T.,et al, 1997

Tuberculous Brain Abscess in a Patient with HIV Infection:Case Report and Review
Am J Med 102:297-301, Farrar,D.J.,et al, 1997

Local Thrombolytic Therapy in Deep Cerebral Venous Thrombosis
Neurol 48:1613-1619, Smith,A.G.,et al, 1997

Endovascular Thrombolysis in Deep Cerebral Venous Thrombosis
AJNR 18:502-506, Spearman,M.P.,et al, 1997

Direct Endovascular Thrombolytic Therapy for Dural Sinus Thrombosis:Infusion of Alteplase
AJNR 18:639-645, Kim,S.Y.&Suh,J.H., 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Stroke Following Central Venous Cannulation
Lancet 349:921, Mainland,P-A.,et al, 1997

Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction
Stroke 28:1107-1114, Sloan,M.A.,et al, 1997

Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997

Hemorrhagic Transformation in Acute Ischemic Stroke
Stroke 28:957-960, Larrue,V.,et al, 1997

Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997

Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997

A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
NINDS Stroke Study Group, Stroke 28:1530-15401997., , 1997

Butorphanol (Stadol) :A Study in Problems of Current Drug Information and Control
Neurol 48:1156-1160, Fisher,M.A.&Glass,S., 1997

Cerebral Infarction in Patients with AIDS
AJNR 18:1581-1585, Gillams,A.R.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2109-21181997., , 1997

Acute Stroke:Usefulness of Early CT Findings Before Thrombolytic Therapy
Radiology 205:327-333, von Kummer,R.,et al, 1997

Total Quality Improvement Method for Reduct of Delays Between ER Dept Adm & Trtm of Acute Ischemic Stroke
Arch Neurol 54:1466-1474, Tilley,B.C.,et al, 1997

MDMA (Ecstasy) and the Rave:A Review
Pediatrics 100:705-708, Schwartz,R.H.&Miller,N.S., 1997

Cocaine and Pupillary-Sparing Oculomotor Nerve Paresis
Neurol 49:1466-1467, Migita,D.S.,et al, 1997



Showing articles 1000 to 1050 of 1724 << Previous Next >>